Funding backs a human-first approach to drug safety and efficacy, reducing reliance on animal testing and accelerating ...

A powerful new treatment has emerged in efforts to reduce high cholesterol levels and the associated risk of heart health problems. In a new trial, the drug enlicitide decanoate was found to lower ...

The U.S. Food and Drug Administration approved an Investigational New Drug (IND) application using efficacy data solely from ...

Commissioner Marty Makary said that the FDA will soon start requiring only one pivotal trial, instead of two, for companies ...

Phase 1 results show that SUL-238 is safe, well-tolerated, and demonstrates favorable pharmacokinetics with high CSF ...

Aggressive cancers can use blood vessels like roadways, speeding through the body and finding new places to grow. But new ...

AI-driven discovery, EHR-based real-world evidence, and synthetic patient modeling are rapidly reshaping drug repurposing, reducing development timelines, expanding therapeutic applications, and ...

The MarketWatch News Department was not involved in the creation of this content. Shanghai, China--(Newsfile Corp. - July 30, 2025) - Frost & Sullivan released a report titled, "Nuoyuan Medical: Class ...

Researchers at the University of Colorado Cancer Center have discovered a novel therapy combination that could offer new hope ...

Researchers have developed a new oral drug that boosts metabolic activity in muscle rather than altering appetite like GLP-1 ...

Okava Pharmaceuticals, a San Francisco based company, plans to introduce on Tuesday a new GLP-1 clinical weight loss study ...